Literature DB >> 31627257

Serological evidence of exposure to ebolaviruses in domestic pigs from Guinea.

Kerstin Fischer1, Alimou Camara2, Cécile Troupin2, Sarah K Fehling3, Thomas Strecker3, Martin H Groschup1, Noel Tordo2, Sandra Diederich1.   

Abstract

The genus Ebolavirus comprises several virus species with zoonotic potential and varying pathogenicity for humans. Ebolaviruses are considered to circulate in wildlife with occasional spillover events into the human population which then often leads to severe disease outbreaks. Several studies indicate a significant role of bats as reservoir hosts in the ebolavirus ecology. However, pigs from the Philippines have been found to be naturally infected with Reston virus (RESTV), an ebolavirus that is thought to only cause asymptomatic infections in humans. The recent report of ebolavirus-specific antibodies in pigs from Sierra Leone further supports natural infection of pigs with ebolaviruses. However, susceptibility of pigs to highly pathogenic Ebola virus (EBOV) was only shown under experimental settings and evidence for natural infection of pigs with EBOV is currently lacking. Between October and December 2017, we collected 308 serum samples from pigs in Guinea, West Africa, and tested for the presence of ebolavirus-specific antibodies with different serological assays. Besides reactivity to EBOV nucleoproteins in ELISA and Western blot for 19 (6.2%) and 13 (4.2%) samples, respectively, four sera recognized Sudan virus (SUDV) NP in Western blot. Furthermore, four samples specifically detected EBOV or SUDV glycoprotein (GP) in an indirect immunofluorescence assay under native conditions. Virus neutralization assay based on EBOV (Mayinga isolate) revealed five weakly neutralizing sera. The finding of (cross-) reactive and weakly neutralizing antibodies suggests the exposure of pigs from Guinea to ebolaviruses or ebola-like viruses with their pathogenicity as well as their zoonotic potential remaining unknown. Future studies should investigate whether pigs can act as an amplifying host for ebolaviruses and whether there is a risk for spillover events.
© 2019 The Authors. Transboundary and Emerging Diseases published by Blackwell Verlag GmbH.

Entities:  

Keywords:  ELISA; Ebola; West Africa; antibodies; ebolaviruses; neutralization test; pigs; serology

Year:  2019        PMID: 31627257     DOI: 10.1111/tbed.13391

Source DB:  PubMed          Journal:  Transbound Emerg Dis        ISSN: 1865-1674            Impact factor:   5.005


  2 in total

1.  High dose of vesicular stomatitis virus-vectored Ebola virus vaccine causes vesicular disease in swine without horizontal transmission.

Authors:  Igor Morozov; Thomas P Monath; David A Meekins; Jessie D Trujillo; Sun-Young Sunwoo; Kinga Urbaniak; In Joong Kim; Sanjeev K Narayanan; Sabarish V Indran; Wenjun Ma; William C Wilson; Cassandra O'Connor; Sheri Dubey; Sean P Troth; Beth-Ann Coller; Richard Nichols; Brian K Martin; Heinz Feldmann; Juergen A Richt
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

2.  Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra Leone.

Authors:  Daniela Manno; Philip Ayieko; David Ishola; Muhammed O Afolabi; Baimba Rogers; Frank Baiden; Alimamy Serry-Bangura; Osman M Bah; Brian Köhn; Ibrahim Swaray; Kwabena Owusu-Kyei; Godfrey T Otieno; Dickens Kowuor; Daniel Tindanbil; Elizabeth Smout; Cynthia Robinson; Babajide Keshinro; Julie Foster; Katherine Gallagher; Brett Lowe; Macaya Douoguih; Bailah Leigh; Brian Greenwood; Deborah Watson-Jones
Journal:  Emerg Infect Dis       Date:  2022-03       Impact factor: 6.883

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.